VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $9,673,000 | -25.2% | 607,618 | -2.3% | 2.68% | -24.8% |
| Q4 2017 | $12,928,000 | +43.4% | 622,146 | -1.1% | 3.57% | +40.8% |
| Q3 2017 | $9,013,000 | -17.8% | 629,003 | -0.8% | 2.54% | -16.1% |
| Q2 2017 | $10,964,000 | +54.9% | 633,787 | -1.2% | 3.02% | +56.8% |
| Q1 2017 | $7,078,000 | -9.2% | 641,738 | +19.5% | 1.93% | -9.1% |
| Q4 2016 | $7,795,000 | -51.1% | 536,894 | -17.4% | 2.12% | -50.0% |
| Q3 2016 | $15,956,000 | +13.3% | 649,959 | +13.4% | 4.24% | +17.3% |
| Q2 2016 | $14,086,000 | +103.2% | 573,321 | +117.5% | 3.62% | +115.4% |
| Q1 2016 | $6,933,000 | -2.4% | 263,641 | +277.3% | 1.68% | +4.3% |
| Q4 2015 | $7,102,000 | – | 69,874 | – | 1.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |